Surprisingly, in both SSc, SSc‐ILD, and IPF patients, regardless of whether in peripheral blood or lung tissue, elevated SPA17 expression was observed in disease groups, correlating positively with disease severity. Here, SPA17 is linked to systemic sclerosis.